These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

181 related articles for article (PubMed ID: 9586944)

  • 61. Interaction of quinoline antimalarial drugs with ferriprotoporphyrin IX, a solid state spectroscopy study.
    Asghari-Khiavi M; Vongsvivut J; Perepichka I; Mechler A; Wood BR; McNaughton D; Bohle DS
    J Inorg Biochem; 2011 Dec; 105(12):1662-9. PubMed ID: 22079977
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Synthesis and evaluation of the antiplasmodial activity of novel indeno[2,1-c]quinoline derivatives.
    Barteselli A; Parapini S; Basilico N; Mommo D; Sparatore A
    Bioorg Med Chem; 2014 Nov; 22(21):5757-65. PubMed ID: 25311562
    [TBL] [Abstract][Full Text] [Related]  

  • 63. New quinoline derivatives demonstrate a promising antimalarial activity against Plasmodium falciparum in vitro and Plasmodium berghei in vivo.
    Soares RR; da Silva JM; Carlos BC; da Fonseca CC; de Souza LS; Lopes FV; de Paula Dias RM; Moreira PO; Abramo C; Viana GH; de Pila Varotti F; da Silva AD; Scopel KK
    Bioorg Med Chem Lett; 2015 Jun; 25(11):2308-13. PubMed ID: 25920564
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Kojic acid derived hydroxypyridinone-chloroquine hybrids: synthesis, crystal structure, antiplasmodial activity and β-haematin inhibition.
    Andayi WA; Egan TJ; Chibale K
    Bioorg Med Chem Lett; 2014 Aug; 24(15):3263-7. PubMed ID: 24974345
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Quinoline-containing antimalarials--mode of action, drug resistance and its reversal. An update with unresolved puzzles.
    Ginsburg H; Krugliak M
    Biochem Pharmacol; 1992 Jan; 43(1):63-70. PubMed ID: 1734899
    [TBL] [Abstract][Full Text] [Related]  

  • 66. The treatment of Plasmodium falciparum-infected erythrocytes with chloroquine leads to accumulation of ferriprotoporphyrin IX bound to particular parasite proteins and to the inhibition of the parasite's 6-phosphogluconate dehydrogenase.
    Famin O; Ginsburg H
    Parasite; 2003 Mar; 10(1):39-50. PubMed ID: 12669348
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Discovery of novel targets of quinoline drugs in the human purine binding proteome.
    Graves PR; Kwiek JJ; Fadden P; Ray R; Hardeman K; Coley AM; Foley M; Haystead TA
    Mol Pharmacol; 2002 Dec; 62(6):1364-72. PubMed ID: 12435804
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Bis-alkylamine Indolo[3,2-b]quinolines as hemozoin ligands: implications for antimalarial cytostatic and cytocidal activities.
    Paulo A; Figueiras M; Machado M; Charneira C; Lavrado J; Santos SA; Lopes D; Gut J; Rosenthal PJ; Nogueira F; Moreira R
    J Med Chem; 2014 Apr; 57(8):3295-313. PubMed ID: 24673163
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Reversal activity of the naturally occurring chemosensitizer malagashanine in Plasmodium malaria.
    Rafatro H; Ramanitrahasimbola D; Rasoanaivo P; Ratsimamanga-Urverg S; Rakoto-Ratsimamanga A; Frappier F
    Biochem Pharmacol; 2000 May; 59(9):1053-61. PubMed ID: 10704934
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Mode of action of antimalarial drugs.
    Fitch CD
    Ciba Found Symp; 1983; 94():222-32. PubMed ID: 6341003
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Digestion of the host erythrocyte by malaria parasites is the primary target for quinoline-containing antimalarials.
    Zarchin S; Krugliak M; Ginsburg H
    Biochem Pharmacol; 1986 Jul; 35(14):2435-42. PubMed ID: 3524576
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Effects of combinations of quinoline-containing antimalarials on Plasmodium falciparum in culture.
    Geary TG; Bonanni LC; Jensen JB; Ginsburg H
    Ann Trop Med Parasitol; 1986 Jun; 80(3):285-91. PubMed ID: 3541805
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Interactions of hemin, antimalarial drugs and hemin-antimalarial complexes with phospholipid monolayers.
    Ginsburg H; Demel RA
    Chem Phys Lipids; 1984 Oct; 35(4):331-47. PubMed ID: 6333931
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Molecular complexes of quinoline antimalarials with iron-porphyrin components of protease-digested methemoglobin.
    Jearnpipatkul A; Panijpan B
    Chem Biol Interact; 1980 Dec; 33(1):83-90. PubMed ID: 7002334
    [TBL] [Abstract][Full Text] [Related]  

  • 75. In vitro studies on the mechanism of action of two compounds with antiplasmodial activity: ellagic acid and 3,4,5-trimethoxyphenyl(6'-O-aalloyl)-beta-D-glucopyranoside.
    Dell'Agli M; Parapini S; Basilico N; Verotta L; Taramelli D; Berry C; Bosisio E
    Planta Med; 2003 Feb; 69(2):162-4. PubMed ID: 12624824
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Neutral lipids associated with haemozoin mediate efficient and rapid β-haematin formation at physiological pH, temperature and ionic composition.
    Ambele MA; Egan TJ
    Malar J; 2012 Oct; 11():337. PubMed ID: 23043460
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Characterization of in vivo metabolites of WR319691, a novel compound with activity against Plasmodium falciparum.
    Milner E; Sousa J; Pybus B; Melendez V; Gardner S; Grauer K; Moon J; Carroll D; Auschwitz J; Gettayacamin M; Lee P; Leed S; McCalmont W; Norval S; Tungtaeng A; Zeng Q; Kozar M; Read KD; Li Q; Dow G
    Eur J Drug Metab Pharmacokinet; 2011 Sep; 36(3):151-8. PubMed ID: 21751074
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Modular synthesis of antimalarial quinoline-based PGM metallarectangles.
    Golding TM; Mbaba M; Smith GS
    Dalton Trans; 2021 Nov; 50(42):15274-15286. PubMed ID: 34633398
    [TBL] [Abstract][Full Text] [Related]  

  • 79.
    Oyeneyin OE; Moodley R; Mashaba C; Garnie LF; Omoboyowa DA; Rakodi GH; Maphoru MV; Balogun MO; Hoppe HC; Egan TJ; Tukulula M
    Heliyon; 2024 Oct; 10(19):e38434. PubMed ID: 39397937
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Identification of an inhibitory pocket in falcilysin provides a new avenue for malaria drug development.
    Wirjanata G; Lin J; Dziekan JM; El Sahili A; Chung Z; Tjia S; Binte Zulkifli NE; Boentoro J; Tham R; Jia LS; Go KD; Yu H; Partridge A; Olsen D; Prabhu N; Sobota RM; Nordlund P; Lescar J; Bozdech Z
    Cell Chem Biol; 2024 Apr; 31(4):743-759.e8. PubMed ID: 38593807
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.